GENEREX BIOTECHNOLOGY CORP (44)
Browse by Contract Category
Contracts
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on September 3, 2020)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on September 3, 2020)
-
MASTER SERVICES AGREEMENT
(Filed With SEC on March 17, 2020)
-
REGISTRATIONRIGHTS AGREEMENT
(Filed With SEC on September 3, 2020)
-
NOTESETTLEMENT AGREEMENT
(Filed With SEC on August 11, 2020)
-
Form of Series C Common Stock Purchase Warrant
(Filed With SEC on August 7, 2020)
-
Form of Series B Common Stock Purchase Warrant
(Filed With SEC on August 7, 2020)
-
Form of Series A Common Stock Purchase Warrant
(Filed With SEC on August 7, 2020)
-
Form of Series D Common Stock Purchase Warrant
(Filed With SEC on August 7, 2020)
-
Registration Rights Agreement dated as of August 4, 2020 between the Company and each other party a signatory thereto
(Filed With SEC on August 7, 2020)
-
Securities Purchase Agreement dated as of August 4, 2020 between the Company and each buyer a signatory thereto
(Filed With SEC on August 7, 2020)
-
WiringInstructions: SignatureBank 565Fifth Avenue NewYork, New York 10017 Routing#: 026013576 Account#: 1502765147 AccountTitle: Carmel, Milazzo & Feil LLP
(Filed With SEC on June 22, 2020)
-
THEISSUE PRICE OF THIS NOTE IS $100,000.00
(Filed With SEC on June 22, 2020)
-
THEISSUE PRICE OF THIS NOTE IS $50,000.00
(Filed With SEC on June 22, 2020)
-
APPENDIXA- Statement of Work
(Filed With SEC on June 8, 2020)
-
LaboratoryServices AGreement
(Filed With SEC on June 8, 2020)
-
X = Y (A-B) A
(Filed With SEC on February 18, 2020)
-
REGISTRATION RIGHTS AGREEMENT
(Filed With SEC on February 18, 2020)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on February 18, 2020)
-
Exhibit 3 Transfer Agent Instructions GENEREX BIOTECHNOLOGY CORPORATION
(Filed With SEC on February 18, 2020)
-
WHEREAS:
(Filed With SEC on February 18, 2020)
-
AMENDMENT AGREEMENT
(Filed With SEC on January 28, 2020)
-
STOCK PURCHASE AGREEMENT CONFIDENTIAL DRAFT: for discussion Purposes ONLY
(Filed With SEC on November 27, 2019)
-
AGREEMENT:
(Filed With SEC on July 16, 2019)
-
RECITALS:
(Filed With SEC on July 16, 2019)
-
RESTRUCTURING AGREEMENT
(Filed With SEC on April 4, 2019)
-
BACKGROUND
(Filed With SEC on February 22, 2019)
-
COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION
(Filed With SEC on February 22, 2019)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on February 22, 2019)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on February 22, 2019)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on February 15, 2019)
-
REGISTRATION RIGHTS AGREEMENT
(Filed With SEC on February 15, 2019)
-
COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION
(Filed With SEC on February 15, 2019)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on February 15, 2019)
-
AMENDMENT AGREEMENT
(Filed With SEC on January 22, 2019)
-
MANAGEMENT SERVICES AGREEMENT
(Filed With SEC on January 11, 2019)
-
PLEDGE AND SECURITY AGREEMENT
(Filed With SEC on January 11, 2019)
-
AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
(Filed With SEC on January 11, 2019)
-
PROMISSORY NOTE CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY
(Filed With SEC on January 11, 2019)
-
STOCK PURCHASE AGREEMENT
(Filed With SEC on January 11, 2019)
-
PROMISSORY NOTE
(Filed With SEC on January 11, 2019)
-
PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY
(Filed With SEC on January 11, 2019)
-
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
(Filed With SEC on January 11, 2019)
-
STOCK PURCHASE AGREEMENT
(Filed With SEC on January 11, 2019)